Skip to main content

Table 1 Characteristics of the COPD population, measured at the random index date

From: Variability of antibiotic prescribing in patients with chronic obstructive pulmonary disease exacerbations: a cohort study

Characteristic

COPD population

 

62,747 (%)

Age at random index date

 

 40–49

2,734 (4.4%)

 50–59

9,253 (14.7%)

 60–69

18,203 (29.0%)

 70–79

19,615 (31.3%)

 80+

12,942 (20.6%)

Male

33,241 (53.0%)

Quintile of Index of Multiple Deprivation

 

 0 (least deprived)

7,153 (11.4%)

 1

11,199 (17.8%)

 2

12,441 (19.8%)

 3

14,801 (23.6%)

 4 (most deprived)

17,033 (27.1%)

Body mass index at random index date

 

 Underweight

6,109 (9.7%)

 Normal

18,556 (29.6%)

 Overweight

18,640 (29.7%)

 Obese

13,224 (21.1%)

 Unknown

6,218 (9.9%)

Smoking status at random index date

 

 Non Smoker

6,586 (10.5%)

 Ex Smoker

30,494 (48.6%)

 Smoker

24,849 (39.6%)

 Unknown

818 (1.3%)

Prescriptions in the previous three months

 

 Antibiotics

23,740 (37.8%)

 Oral glucocorticoid therapies

10,645 (17.0%)

 Anticholinergics

21,104 (33.6%)

Medical history

 

 Hypertension

24,245 (38.6%)

 Diabetes

8,322 (13.3%)

 Heart Failure

5,132 (8.2%)

 Depression

18,282 (29.1%)

Forced expiratory volume in one second (FEV1) as proportion of predicted

 

 Mild COPD (≥80)

2,699 (4.3%)

 Moderate COPD (50–<80%)

10,434 (16.6%)

 Severe COPD (30–< 50%)

20,283 (32.3%)

 Very severe COPD (<30%)

8,095 (12.9%)

 Unknown

21,236 (33.8%)